Reaxys Announces Winners of the 2012 Reaxys PhD Prize
NEUCHÃ‚TEL, Switzerland, June 19, 2012 /PRNewswire/ –
The Reaxys PhD Prize awards original and innovative research in organic,
organometallic and inorganic chemistry
Reaxys announces the winners of the Reaxys PhD Prize. Awarding innovative and original
research in organic, organometallic and inorganic chemistry, the Reaxys PhD Prize
celebrates the top research being performed by leading young chemists across the globe.
The 2012 Reaxys PhD Prize Winners are:
- Gregory Hamilton at University of California, Berkeley USA - Debashis Mandal at Nagoya University, Japan - Craig Stivala, University of California, Santa Barbara, USA
The winners have been selected from 45 finalists (see http://prize.reaxys.com for
details of all the finalists) by the Chairs of the Review Board: Professors Tony Barrett
(Imperial College, UK), Barry Trost (Stanford, USA) and Henry Wong (Chinese University
Hong Kong, China).
Professor Wong said, “The prize goes from strength to strength. The three winners feel
very proud to have been selected from such a strong and diverse field of applicants. I am
personally very pleased to see such a diverse set of chemistries represented. This year
there were a significant number of inorganic and organometallic submissions in addition to
the usual strong organic submissions. I am sure that all of these young chemists have
extremely bright futures ahead of them.”
Launched in January 2010 the Reaxys PhD Prize has received over 900 submissions from
well over 400 of the world’s top chemistry institutions. This year a record 350
submissions were received from 39 countries. Submissions consisted of a representative
peer-reviewed piece of published research, PhD supervisor’s recommendation letter and a
CV. Entries were closely scrutinized by a review board of over 80 international chemists
from academia and industry. The reviewers judged the entries for originality, innovation,
importance to the field, applicability, rigor of approach and publication quality.
The three winners and 42 other finalists have each been invited to attend the Reaxys
PhD Prize Symposium at the 244th American Chemical Society Meeting in Philadelphia, on
Sunday August 19 2012. The winners are invited to give an oral presentation of their
research, and the finalists will participate in a special poster session and reception.
The symposium will also feature presentations from Professors Martin Jansen (Max-Planck,
Stuttgart, Germany) and Barry Trost (Stanford, USA)
To learn more about the Reaxys PhD Prize please visit http://prize.reaxys.com.
To learn more about Reaxys(R) please visit http://www.reaxys.com. Reaxys(R) and
the Reaxys(R) trademark are owned and protected by Reed Elsevier Properties SA and used
# # #
Reaxys(R) is a workflow solution for research chemists. Offering a wealth of
experimentally validated information, Reaxys(R) combines reaction and substance data in
organic, organometallic, inorganic and physical chemistry with synthesis planning.
Researchers can get the information they need in a single overview, from source
publications carefully selected for their importance and relevance to research chemists.
Elsevier continues to engage with the chemistry community to ensure that Reaxys(R)
continues to reflect how chemists think and work. For more information please visit
Reaxys and the Reaxys trademark are owned and protected by Reed Elsevier Properties SA
and used under license.
Elsevier is a world-leading provider of scientific, technical and medical information
products and services. The company works in partnership with the global science and health
communities to publish more than 2,000 journals, including The Lancet
[http://www.thelancet.com ] and Cell [http://www.cell.com ], and close to 20,000 book
titles, including major reference works from Mosby and Saunders. Elsevier’s online
solutions include ScienceDirect [http://www.sciencedirect.com ], Scopus
[http://www.scopus.com ], Reaxys [http://www.reaxys.com ], MD Consult
[http://www.mdconsult.com ] and Mosby’s Nursing Suite [http://www.confidenceconnected.com
], which enhance the productivity of science and health professionals, and the SciVal
suite [http://www.scival.com ] and MEDai’s Pinpoint Review [http://www.medai.com ], which
help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier [http://www.elsevier.com ]
employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC
[http://www.reedelsevier.com ], a world-leading publisher and information provider, which
is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN
(Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
About Reed Elsevier Properties SA
Reed Elsevier Properties SA is a centre of excellence within Reed Elsevier for the
management, development and protection of intellectual property. Reed Elsevier Properties
SA owns the PharmaPendium and Reaxys databases. Trademarks including Reaxys(R),
PharmaPendium(R), Targetinsights(TM), The Lancet(R) and World Travel Market(R) are owned
and protected by Reed Elsevier Properties SA and used under licence.
Media contact Tom Reller Vice President, Global Corporate Relations, Elsevier +1-215-239-3508 email@example.com